Quorum Sensing Inhibition Selects for Virulence and Cooperation in
With the rising development of bacterial resistance the search for new medical treatments beyond conventional antimicrobials has become a key aim of public health research. Possible innovative strategies include the inhibition of bacterial virulence. However, consideration must be given to the evolutionary and environmental consequences of such new interventions. Virulence and cooperative social behaviour of the bacterium Pseudomonas aeruginosa rely on the quorum-sensing (QS) controlled production of extracellular products (public goods). Hence QS is an attractive target for anti-virulence interventions. During colonization, non-cooperating (and hence less virulent) P. aeruginosa QS-mutants, benefiting from public goods provided by wild type isolates, naturally increase in frequency providing a relative protection from invasive infection. We hypothesized that inhibition of QS-mediated gene expression removes this growth advantage and selection of less virulent QS-mutants, and maintains the predominance of more virulent QS-wild type bacteria. We addressed this possibility in a placebo-controlled trial investigating the anti-QS properties of azithromycin, a macrolide antibiotic devoid of bactericidal activity on P. aeruginosa, but interfering with QS, in intubated patients colonized by P. aeruginosa. In the absence of azithromycin, non-cooperating (and hence less virulent) lasR (QS)-mutants increased in frequency over time. Azithromycin significantly reduced QS-gene expression measured directly in tracheal aspirates. Concomitantly the advantage of lasR-mutants was lost and virulent wild-type isolates predominated during azithromycin treatment. We confirmed these results in vitro with fitness and invasion experiments. Azithromycin reduced growth rate of the wild-type, but not of the lasR-mutant. Furthermore, the lasR-mutant efficiently invaded wild-type populations in the absence, but not in the presence of azithromycin. These in vivo and in vitro results demonstrate that anti-virulence interventions based on QS-blockade diminish natural selection towards reduced virulence and therefore may increase the prevalence of more virulent genotypes in the Hospital environment. More generally, the impact of intervention on the evolution of virulence of pathogenic bacteria should be assessed.
Trial Registration: ClinicalTrials.gov NCT00610623
Vyšlo v časopise:
Quorum Sensing Inhibition Selects for Virulence and Cooperation in. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000883
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000883
Souhrn
With the rising development of bacterial resistance the search for new medical treatments beyond conventional antimicrobials has become a key aim of public health research. Possible innovative strategies include the inhibition of bacterial virulence. However, consideration must be given to the evolutionary and environmental consequences of such new interventions. Virulence and cooperative social behaviour of the bacterium Pseudomonas aeruginosa rely on the quorum-sensing (QS) controlled production of extracellular products (public goods). Hence QS is an attractive target for anti-virulence interventions. During colonization, non-cooperating (and hence less virulent) P. aeruginosa QS-mutants, benefiting from public goods provided by wild type isolates, naturally increase in frequency providing a relative protection from invasive infection. We hypothesized that inhibition of QS-mediated gene expression removes this growth advantage and selection of less virulent QS-mutants, and maintains the predominance of more virulent QS-wild type bacteria. We addressed this possibility in a placebo-controlled trial investigating the anti-QS properties of azithromycin, a macrolide antibiotic devoid of bactericidal activity on P. aeruginosa, but interfering with QS, in intubated patients colonized by P. aeruginosa. In the absence of azithromycin, non-cooperating (and hence less virulent) lasR (QS)-mutants increased in frequency over time. Azithromycin significantly reduced QS-gene expression measured directly in tracheal aspirates. Concomitantly the advantage of lasR-mutants was lost and virulent wild-type isolates predominated during azithromycin treatment. We confirmed these results in vitro with fitness and invasion experiments. Azithromycin reduced growth rate of the wild-type, but not of the lasR-mutant. Furthermore, the lasR-mutant efficiently invaded wild-type populations in the absence, but not in the presence of azithromycin. These in vivo and in vitro results demonstrate that anti-virulence interventions based on QS-blockade diminish natural selection towards reduced virulence and therefore may increase the prevalence of more virulent genotypes in the Hospital environment. More generally, the impact of intervention on the evolution of virulence of pathogenic bacteria should be assessed.
Trial Registration: ClinicalTrials.gov NCT00610623
Zdroje
1. HentzerM
WuH
AndersenJB
RiedelK
RasmussenTB
2003 Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22 3803 3815
2. BjarnsholtT
GivskovM
2007 Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 362 1213 1222
3. Van DeldenC
IglewskiBH
1998 Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4 551 560
4. MolinariG
GuzmanCA
PesceA
SchitoGC
1993 Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31 681 688
5. TatedaK
ComteR
PechereJC
KöhlerT
YamaguchiK
2001 Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45 1930 1933
6. DiggleSP
GriffinAS
CampbellGS
WestSA
2007 Cooperation and conflict in quorum-sensing bacterial populations. Nature 450 411 414
7. SandozKM
MitzimbergSM
SchusterM
2007 Social cheating in Pseudomonas aeruginosa quorum sensing. Proc Natl Acad Sci U S A 104 15876 15881
8. KöhlerT
BucklingA
Van DeldenC
2009 Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc Natl Acad Sci U S A 106 6339 6344
9. BrownSP
HochbergME
GrenfellBT
2002 Does multiple infection select for raised virulence? Trends Microbiol 10 401 405
10. WestSA
BucklingA
2003 Cooperation, virulence and siderophore production in bacterial parasites. Proc Biol Sci 270 37 44
11. BucklingA
BrockhurstMA
2008 Kin selection and the evolution of virulence. Heredity 100 484 488
12. SmithEE
BuckleyDG
WuZ
SaenphimmachakC
HoffmanLR
2006 Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103 8487 8492
13. D'ArgenioDA
WuM
HoffmanLR
KulasekaraHD
DezielE
2007 Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64 512 533
14. HeurlierK
DenervaudV
HaenniM
GuyL
KrishnapillaiV
2005 Quorum-sensing-negative (lasR) mutants of Pseudomonas aeruginosa avoid cell lysis and death. J Bacteriol 187 4875 4883
15. GandonS
MackinnonMJ
NeeS
ReadAF
2001 Imperfect vaccines and the evolution of pathogen virulence. Nature 414 751 756
16. NalcaY
JanschL
BredenbruchF
GeffersR
BuerJ
2006 Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50 1680 1688
17. PearsonJP
PesciEC
IglewskiBH
1997 Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 179 5756 5767
18. DuanK
DammelC
SteinJ
RabinH
SuretteMG
2003 Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50 1477 1491
19. DanesiR
LupettiA
BarbaraC
GhelardiE
ChellaA
2003 Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother 51 939 945
20. Le BerreR
NguyenS
NowakE
KipnisE
PierreM
2008 Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 14 337 343
21. SmithRS
IglewskiBH
2003 P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 6 56 60
22. RumbaughKP
DiggleSP
WattersCM
Ross-GillespieA
GriffinAS
2009 Quorum sensing and the social evolution of bacterial virulence. Curr Biol 19 341 345
23. HarrisonEF
BrowningL
VosM
BucklingA
2006 Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biology 4 21
24. BrownSP
JohnstoneRA
2001 Cooperation in the dark: signalling and collective action in quorum-sensing bacteria. Proc Biol Sci 268 961 965
25. KöhlerT
Kocjancic-CurtyL
BarjaF
Van DeldenC
PechèreJC
2000 Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 182 5990 5996
26. LenskiRE
RoseMR
SimpsonSC
TadlerSC
1991 Long term experimental evolution in Escherichia coli. 1. Adaptation and divergence during 2000 generations. Am Nat 138 1315 1341
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
- Susceptibility to Anthrax Lethal Toxin-Induced Rat Death Is Controlled by a Single Chromosome 10 Locus That Includes
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species